Intraspinal transplantation of autologous neurogenically-induced bone marrow-derived mesenchymal stem cells in the treatment of paraplegic dogs without deep pain perception secondary to intervertebral disk disease

Turkish Neurosurgery

Volumn 25, Issue 4, 2015, Pages 625-632

  Besalti, Omer ^a   Can, Pinar ^a   Akpinar, Eylul ^a   Aktas, Zeynep ^a   Elcin, Ayse Eser ^a   Elcin, Yasar Murat ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Dog; Intervertebral disk disease; Mesenchymal stem cells (MSCs); Spinal cord injury

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; TUBULIN;

ANIMAL; AUTOTRANSPLANTATION; BONE MARROW CELL; COMPLICATION; DOG; DOG DISEASES; INTERVERTEBRAL DISC DEGENERATION; INTERVERTEBRAL DISC DISPLACEMENT; LAMENESS, ANIMAL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; NEURAL STEM CELL; NEUROLOGIC EXAMINATION; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PROCEDURES; SPINAL CORD; SURGERY; TREATMENT OUTCOME; VETERINARY;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; BONE MARROW CELLS; DOG DISEASES; DOGS; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERVERTEBRAL DISC DEGENERATION; INTERVERTEBRAL DISC DISPLACEMENT; LAMENESS, ANIMAL; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEURAL STEM CELLS; NEUROLOGIC EXAMINATION; PAIN PERCEPTION; PARAPLEGIA; SPINAL CORD; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; TUBULIN;

EID: 84938372223     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: 10.5137/1019-5149.JTN.14502-15.2     Document Type: Article

References (40)

1. Aghayan HR, Arjmand B, Yaghoubi M, Moradi-Lakeh M, Kashani H, Shokraneh F: Clinical outcome of autologous mononuclear cells transplantation for spinal cord injury; A systematic review and meta-analysis. Med J Islam Repub Iran 28: 112-120, 2014
2. Akiyama Y, Radtke C, Kocsis JD: Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 22: 6623-6630, 2002
3. Anderson SM, Lippincott CL, Gill PJ: Hemilaminectomy in dogs without deep pain perception. California Vet 45: 24-28, 1991
4. Baykan E, Koc A, Elcin AE, Elcin YM: Evaluation of a biomimetic poly (ε-caprolactone)/β tricalcium phosphate multispiral scaffold for bone tissue engineering: In vitro and in vivo studies. Biointerphases 9(2): 029011, 2014
5. Besalti O, Ozak A, Pekcan Z, Tong S, Eminaga S, Tacal T: The role of extruded disk material in thoracolumbar intervertebral disk disease: A retrospective study in 40 dogs. Can Vet J 46(9): 814, 2005
6. Besalti O, Pekcan Z, Sirin YS, Erbas G: Magnetic resonance imaging findings in dogs with thoracolumbar intervertebral disk disease: 69 cases (1997-2005). J Am Vet Medl Assoc 228(6): 902-908, 2006
7. Blight AR: Cellular morphology of chronic spinal cord injury in the cat: Analysis of myelinated axons by line-sampling. Neuroscience 10: 521-543, 1983
8. Brown NO, Helphrey ML, Prata RG: Thoracolumbar disk disease in the dog: A retrospective analysis of 187 cases. J Am Anim Hosp Assoc 13: 665-672, 1977
9. Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, Lu M, Rosenblum M: Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation. Neuroreport 11: 3001-3005, 2000
10. Chung WH, Park SA, Lee JH, Chung DJ, Yang WJ, Kang EH, Choi CB, Chang HS, Kim DH, Hwang SH, Han H, Kim HY: Percutaneous transplantation of human umbilical cordderived mesenchymal stem cells in a dog suspected to have fibrocartilaginous embolic myelopathy. J Vet Sci 14(4): 495-497, 2013
11. Elcin YM (ed). Tissue engineering, stem cells, and gene therapies. Vol. 534. Springer US: Springer Science & Business Media, 2003: 1-340
12. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, Bartlett, PF, Blight AR, Dietz V, Ditunno, J: Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45: 190-205, 2007
13. Fehlings MG, Vawda R: Cellular treatments for spinal cord injury. The time is right for clinical trials. Neurotherapeutics 8(4): 704-720, 2011
14. Granger N, Blamires H, Franklin RJ, Jeffery ND: Autologous olfactory mucosal cell transplants in clinical spinal cord injury: A randomized double-blinded trial in a canine translational model. Brain 135(11): 3227-3237, 2012
15. Hyatt AJ, Wang D, van Oterendorp C, Fawcett JW, Martin KR: Mesenchymal stromal cells integrate and form longitudinallyaligned layers when delivered to injured spinal cord via a novel fibrin scaffold. Neuroscience Letters 569: 12-17, 2014
16. Jeffery ND, Lakatos A, Franklin RJ: Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury. J Neurotrauma 22: 1282-1293, 2005
17. Jung DI, Ha J, Kang BT, Kim JW, Quan FS, Lee JH, Park HM: A comparison of autologous and allogenic bone marrowderived mesenchymal stem cell transplantation in canine spinal cord injury. J Neurol Sci 285(1): 67-77, 2009
18. Laitinen OM, Puerto DA: Surgical decompression in dogs with thoracolumbar intervertebral disc disease and loss of deep pain perception: A retrospective study of 46 cases. Acta Vet Scand 46(1-2): 79-85, 2005
19. Lee JH, Chang HS, Kang EH, Chung DJ, Choi CB, Lee JH, Hwang SH, Han H, Kim HY: Percutaneous transplantation of human umbilical cord blood-derived multipotent stem cells in a canine model of spinal cord injury. J Neurosurg Spine 11: 749-757, 2009
20. Lee JH, Chung WH, Kang EH, Chung DJ, Choi CB, Chang HS, Kim HY: Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)- derived mesenchymal stem cells in dogs with acute spinal cord injury. J Neurol Sci 300(1-2): 86-96, 2011
21. Levine GJ, Levine JM, Budke CM, Kerwin SC, Au J, Vinayak A, Hettlich BF, Slater MR: Description and repeatability of a newly developed spinal cord injury scale for dogs. Prev Vet Med 89(1-2): 121-127, 2009
22. Lim JH, Boozer L, Mariani CL, Piedrahita JA, Olby NJ: Generation and characterization of neurospheres from canine adipose tissue-derived stromal cells. Cell Reprogram 12(4): 417-425, 2010
23. McDonald JW: Repairing the damaged spinal cord: From stem cells to activity-based restoration therapies. Clinical Neurosurgery 51: 207-227, 2003
24. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, et al: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5: 1410-1412, 1999
25. Moore SA, Oglesbee MJ: Spinal cord ependymal responses to naturally occurring traumatic spinal cord injury in dogs. Vet Pathol 2014, (Epub ahead of print)
26. Muñoz-Elías G, Woodbury D, Black IB: Marrow stromal cells, mitosis, and neuronal differentiation: Stem cell and precursor functions. Stem Cells 21: 437-448, 2003
27. Odabas S, Elcin AE, Elcin YM: Isolation and characterization of mesenchymal stem cells. Method Mol Biol 1109: 47-63, 2014
28. Olby N, Levine J, Harris T, Muñana K, Skeen T, Sharp N: Longterm functional outcome of dogs with severe injuries of the thoracolumbar spinal cord: 87 cases (1996-2001). J Am Vet Med Assoc 222: 762-769, 2003
29. Oudega M: Schwann cell and olfactory ensheathing cell implantation for repair of the contused spinal cord. Acta Physiol 189: 181-189, 2007
30. Park SS, Lee YJ, Lee SH, Lee D, Choi K, Kim WH, Han HJ: Functional recovery after spinal cord injury in dogs treated with a combination of Matrigel and neural-induced adiposederived mesenchymal stem cells. Cytotherapy 14(5): 584-597, 2012
31. Penha EM, Meira CS, Guimarães ET, Mendonça MVP, Gravely FA, Pinheiro CMB, Pinheiro TMB, Barroin-Melo SM, Ribeirodos-Santos R, Soares MBP: Use of autologous mesenchymal stem cells derived from bone marrow for the treatment of naturally injured spinal cord in dogs. Stem Cells International February 2014; 8. Available from: Hindawi Publishing Corporation. Accessed February 15, 2015
32. Ryu HH, Kang BJ, Park SS, Kim Y, Sung GJ, Woo HM, Kim WH, Kweon OK: Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci 74(12): 1617-1630, 2012
33. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164: 247-256, 2000
34. Scott HW, McKee WM: Laminectomy for 34 dogs with thoracolumbar intervertebral disc disease and loss of deep pain perception. J Small Anim Pract 40(9): 417-422, 1999
35. Sirin YS, Keles H, Besalti O, Atalay Vural S: Comparison of ATPMgCl2 and methylprednisolone in experimentally induced spinal cord trauma. J Clin Anal Med 3(4): 442-447, 2012
36. Tohda C, Kuboyama T: Current and future therapeutic strategies for functional repair of spinal cord injury. Pharmacology & Therapeutics 132 (1): 57-71, 2011
37. Vaquero J, Zurita M, Oya S, Santos M: Cell therapy using bone marrow stromal cells in chronic paraplegic rats: Systemic or local administration? Neurosci Lett 398(1-2): 129-134, 2006
38. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J, Sanberg PR: Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. Journal of Neuroscience Research 73: 296-307, 2003
39. Wu S, Suzuki Y, Ejiri Y, Noda T, Bai H, Kitada M, Kataoka K, Ohta M, Chou H, Ide C: Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res 72(3): 343-351, 2003
40. Yilmaz T, Kaptanoglu E: Current and future medical therapeutic strategies for the functional repair of spinal cord injury. World Journal of Orthopedics 6(1): 42-55, 2015